TrialCancer communications (London, England)2019

The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer.

Zhi-Qiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.